Literature DB >> 29037660

NMDA receptor blockade specifically impedes the acquisition of incentive salience attribution.

Jonathan J Chow1, Joshua S Beckmann2.   

Abstract

Glutamatergic signaling plays an important role in learning and memory. Using Pavlovian conditioned approach procedures, the mechanisms that drive stimulus-reward learning and memory have been investigated. However, there are instances where reward-predictive stimuli can function beyond being solely predictive and can be attributed with "motivational value" or incentive salience. Using a Pavlovian conditioned approach procedure consisting of two different but equally predictive stimuli (lever vs. tone) we investigated the role NMDA receptor function has in the attribution of incentive salience. The results revealed that the administration of MK-801, an NMDA receptor antagonist, during acquisition of Pavlovian conditioned approach promoted goal-tracking to a lever stimulus, while control animals learned to sign-track. Moreover, within the same animals, the use of a tone stimulus elicited goal-tracking responses that were unaffected by MK-801 pretreatments. Furthermore, a lever CS that elicited sign-tracking served as a more robust conditioned reinforcer than a tone CS that elicited goal-tracking or a lever CS that elicited goal-tracking via MK-801 pretreatments. Collectively, these results demonstrate that NMDA receptor antagonism can alter the stimulus-reward relationship learned and prevent the attribution of incentive salience, rather than impede general learning.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glutamate; Goal-tracking; Incentive salience; MK-801; Sign-tracking

Mesh:

Substances:

Year:  2017        PMID: 29037660      PMCID: PMC5681870          DOI: 10.1016/j.bbr.2017.10.013

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  35 in total

Review 1.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

Review 2.  Neurobiology of Pavlovian fear conditioning.

Authors:  S Maren
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 3.  Structural plasticity and memory.

Authors:  Raphael Lamprecht; Joseph LeDoux
Journal:  Nat Rev Neurosci       Date:  2004-01       Impact factor: 34.870

4.  A progression for generating variable-interval schedules.

Authors:  M FLESHLER; H S HOFFMAN
Journal:  J Exp Anal Behav       Date:  1962-10       Impact factor: 2.468

Review 5.  Molecular mechanisms of memory reconsolidation.

Authors:  Natalie C Tronson; Jane R Taylor
Journal:  Nat Rev Neurosci       Date:  2007-04       Impact factor: 34.870

Review 6.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 7.  Pavlovian conditioning and its proper control procedures.

Authors:  R A Rescorla
Journal:  Psychol Rev       Date:  1967-01       Impact factor: 8.934

8.  Auto-shaping of the pigeon's key-peck.

Authors:  P L Brown; H M Jenkins
Journal:  J Exp Anal Behav       Date:  1968-01       Impact factor: 2.468

9.  Effects of nucleus accumbens core and shell lesions on autoshaped lever-pressing.

Authors:  Stephen E Chang; Peter C Holland
Journal:  Behav Brain Res       Date:  2013-08-06       Impact factor: 3.332

Review 10.  Behavioral dopamine signals.

Authors:  Wolfram Schultz
Journal:  Trends Neurosci       Date:  2007-04-02       Impact factor: 13.837

View more
  2 in total

1.  The role of glutamate signaling in incentive salience: second-by-second glutamate recordings in awake Sprague-Dawley rats.

Authors:  Seth R Batten; Francois Pomerleau; Jorge Quintero; Greg A Gerhardt; Joshua S Beckmann
Journal:  J Neurochem       Date:  2018-05-15       Impact factor: 5.372

2.  Amantadine Did Not Positively Impact Cognition in Chronic Traumatic Brain Injury: A Multi-Site, Randomized, Controlled Trial.

Authors:  Flora M Hammond; Mark Sherer; James F Malec; Ross D Zafonte; Sureyya Dikmen; Jennifer Bogner; Kathleen R Bell; Jason Barber; Nancy Temkin
Journal:  J Neurotrauma       Date:  2018-06-07       Impact factor: 5.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.